Topotecan and cladribine with filgrastim support in relapsed, refractory and poor prognosis leukemias: A phase I-II study

被引：0
|
作者：
Silverman, LR [1 ]
Isola, L [1 ]
Brenner, R [1 ]
Gabrilove, J [1 ]
Mandeli, J [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6724
引用
收藏
页码：613S / 613S
页数：1
相关论文
共 50 条
  • [21] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study
    Vey, N
    Kantarjian, H
    Beran, M
    O'Brien, S
    Cortes, J
    Koller, C
    Estey, E
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 89 - 95
  • [22] Effective dosing of topotecan with carboplatin in relapsed ovarian cancer: A phase I/II study
    Bowman, A
    Rye, T
    Ross, G
    Wheatley, A
    Smyth, JF
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) : 3255 - 3259
  • [23] PHASE-II STUDY OF BISANTRENE IN RELAPSED REFRACTORY ACUTE NON LYMPHOID LEUKEMIAS (ANLL)
    TOSI, P
    VISANI, G
    COLOMBINI, R
    VERLICCHI, F
    BENFENATI, D
    CENACCHI, A
    RUSSO, D
    ZUFFA, E
    PAPADOPULU, P
    TURA, S
    HAEMATOLOGICA, 1989, 74 (06) : 555 - 558
  • [24] Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Chen, Christine
    Trudel, Suzanne
    Kukreti, Vishal
    Mikhael, Joseph
    Pantoja, Mariela
    Xu, Wei
    Stewart, A. Keith
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4777 - 4783
  • [25] Phase I Study of Palbociclib Alone and in Combination in Patients with Relapsed and Refractory (R/R) Leukemias
    Kadia, Tapan M.
    Konopleva, Marina Y.
    Garcia-Manero, Guillermo
    Benton, Christopher B.
    Wierda, William G.
    Bose, Prithviraj
    Yilmaz, Musa E.
    Jabbour, Elias J.
    Kornblau, Steven M.
    Bhalla, Kapil N.
    Pemmaraju, Naveen
    Jain, Nitin
    Malla, Rashmi
    Borthakur, Gautam
    Cortes, Jorge E.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    BLOOD, 2018, 132
  • [26] Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias
    Blum, William
    Phelps, Mitch A.
    Klisovic, Rebecca B.
    Rozewski, Darlene M.
    Ni, Wenjun
    Albanese, Katie A.
    Rovin, Brad
    Kefauver, Cheryl
    Devine, Steven M.
    Lucas, David M.
    Johnson, Amy
    Schaaf, Larry J.
    Byrd, John C.
    Marcucci, Guido
    Greyer, Michael R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1098 - 1105
  • [27] A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma
    Larry E. Puls
    Bunny Phillips
    Chris Schammel
    James E. Hunter
    David Griffin
    Medical Oncology, 2010, 27 : 368 - 372
  • [28] Melphalan, Thalidomide and Prednisone (MPT) Combined with Oral Panobinostat In Patients with Relapsed/Refractory MM: a Phase I-II Study.
    Offidani, Massimo
    Cavallo, Federica
    Polloni, Claudia
    Liberati, Anna Marina
    Ballanti, Stelvio
    Pulini, Stefano
    Catarini, Massimo
    Alesiani, Francesco
    Corvatta, Laura
    Gentili, Silvia
    Boccadoro, Mario
    Leoni, Pietro
    Palumbo, Antonio
    BLOOD, 2010, 116 (21) : 1243 - 1244
  • [29] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study.
    Vey, N
    Kantarjian, H
    Beran, M
    O'Brien, S
    Cortes, J
    Giles, FJ
    Koller, C
    Estey, E
    BLOOD, 1998, 92 (10) : 235A - 235A
  • [30] A phase I-II trial of weekly topotecan in the treatment of recurrent cervical carcinoma
    Puls, Larry E.
    Phillips, Bunny
    Schammel, Chris
    Hunter, James E.
    Griffin, David
    MEDICAL ONCOLOGY, 2010, 27 (02) : 368 - 372
12345